Evaluation of Efficacy and Safety of Ponatinib as Third-line Treatment in Patients with the Diagnosis of Chronic Phase Chronic Myeloid Leukemia

Makaleler > Tam Makale · 2016

Yazarlar: PUSEM PATIR

International Journal of Hematology and Oncology, Uluslararası, Wos, 2016, cilt 26, ss 224-226